| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 1e-05 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |